Arturo LoAlza-Bonilla: Shaping the Future of Oncology and AI
Arturo LoAlza-Bonilla, Co-Founder and Chief Medical Officer at Massive Bio, posted the following on LinkedIn:
“I am thrilled to announce my official appointment as Systemwide Chief of Hematology and Oncology at St. Luke’s University Health Network and Associate Professor of Medicine at the Lewis Katz School of Medicine at Temple University!
This incredible opportunity allows me to lead a dynamic oncology team spanning 15 hospitals across 11 counties in Pennsylvania and New Jersey, all part of a nationally recognized healthcare system. St. Luke’s is home to the only medical school in the region and a major teaching hospital with over 600 trainees, including established fellowship programs that are shaping the future of oncology care.
In this role, I am excited to further enhance precision oncology, expand access to clinical trials, and foster team-based, multidisciplinary excellence in cancer care.
At the same time, I cannot be more excited to continue my entrepreneurial journey with Massive Bio, leveraging the transformative power of AI to revolutionize clinical trial access and bring innovative treatments to patients globally. These complementary roles fuel my mission to bridge cutting-edge technology and compassionate care for better outcomes.
I look forward to collaborating with colleagues, students, and partners to advance innovation in oncology and AI. Together, we’ll shape the future of cancer care and inspire the next generation of leaders in the field.
Let’s make an impact where it matters most—at the intersection of science, technology, and care.”
More posts featuring Arturo LoAIza-Bonilla.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023